nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—Cystoid macular oedema—Niacin—atherosclerosis	0.0442	0.0965	CcSEcCtD
Bimatoprost—Macular oedema—Niacin—atherosclerosis	0.019	0.0415	CcSEcCtD
Bimatoprost—Common cold—Pravastatin—atherosclerosis	0.0175	0.0382	CcSEcCtD
Bimatoprost—Iloprost—PLAT—atherosclerosis	0.0136	0.838	CrCbGaD
Bimatoprost—Urine analysis abnormal—Rosuvastatin—atherosclerosis	0.0108	0.0237	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Niacin—atherosclerosis	0.00779	0.017	CcSEcCtD
Bimatoprost—Cough increased—Rosuvastatin—atherosclerosis	0.00695	0.0152	CcSEcCtD
Bimatoprost—Burning sensation—Niacin—atherosclerosis	0.00667	0.0146	CcSEcCtD
Bimatoprost—Eye irritation—Lovastatin—atherosclerosis	0.00632	0.0138	CcSEcCtD
Bimatoprost—Cataract—Lovastatin—atherosclerosis	0.00567	0.0124	CcSEcCtD
Bimatoprost—Inflammation—Ezetimibe—atherosclerosis	0.00545	0.0119	CcSEcCtD
Bimatoprost—Cataract—Simvastatin—atherosclerosis	0.0053	0.0116	CcSEcCtD
Bimatoprost—Inflammation—Simvastatin—atherosclerosis	0.0052	0.0114	CcSEcCtD
Bimatoprost—Skin discolouration—Niacin—atherosclerosis	0.00513	0.0112	CcSEcCtD
Bimatoprost—Cough increased—Niacin—atherosclerosis	0.00506	0.0111	CcSEcCtD
Bimatoprost—Cataract—Pravastatin—atherosclerosis	0.00479	0.0105	CcSEcCtD
Bimatoprost—Arthritis—Lovastatin—atherosclerosis	0.00403	0.0088	CcSEcCtD
Bimatoprost—Arthritis—Ezetimibe—atherosclerosis	0.00395	0.00863	CcSEcCtD
Bimatoprost—Bronchitis—Rosuvastatin—atherosclerosis	0.00384	0.00839	CcSEcCtD
Bimatoprost—Arthritis—Simvastatin—atherosclerosis	0.00377	0.00823	CcSEcCtD
Bimatoprost—Depression—Rosuvastatin—atherosclerosis	0.00355	0.00776	CcSEcCtD
Bimatoprost—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00355	0.00775	CcSEcCtD
Bimatoprost—Arthritis—Niacin—atherosclerosis	0.00346	0.00756	CcSEcCtD
Bimatoprost—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00343	0.0075	CcSEcCtD
Bimatoprost—Arthritis—Pravastatin—atherosclerosis	0.00341	0.00744	CcSEcCtD
Bimatoprost—Sinusitis—Rosuvastatin—atherosclerosis	0.00334	0.0073	CcSEcCtD
Bimatoprost—Diplopia—Pravastatin—atherosclerosis	0.00331	0.00723	CcSEcCtD
Bimatoprost—Rhinitis—Rosuvastatin—atherosclerosis	0.0032	0.007	CcSEcCtD
Bimatoprost—Pharyngitis—Rosuvastatin—atherosclerosis	0.00317	0.00693	CcSEcCtD
Bimatoprost—Liver function test abnormal—Niacin—atherosclerosis	0.0031	0.00678	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00308	0.00674	CcSEcCtD
Bimatoprost—Dry skin—Niacin—atherosclerosis	0.00308	0.00673	CcSEcCtD
Bimatoprost—Liver function test abnormal—Pravastatin—atherosclerosis	0.00306	0.00668	CcSEcCtD
Bimatoprost—Bronchitis—Simvastatin—atherosclerosis	0.00304	0.00665	CcSEcCtD
Bimatoprost—Dry skin—Pravastatin—atherosclerosis	0.00303	0.00663	CcSEcCtD
Bimatoprost—Nasopharyngitis—Pravastatin—atherosclerosis	0.00296	0.00647	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00294	0.00643	CcSEcCtD
Bimatoprost—Sinusitis—Lovastatin—atherosclerosis	0.00283	0.00619	CcSEcCtD
Bimatoprost—Depression—Simvastatin—atherosclerosis	0.00281	0.00615	CcSEcCtD
Bimatoprost—Bronchitis—Niacin—atherosclerosis	0.00279	0.00611	CcSEcCtD
Bimatoprost—Sinusitis—Ezetimibe—atherosclerosis	0.00278	0.00607	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00266	0.00581	CcSEcCtD
Bimatoprost—Sinusitis—Simvastatin—atherosclerosis	0.00265	0.00579	CcSEcCtD
Bimatoprost—Pharyngitis—Ezetimibe—atherosclerosis	0.00264	0.00576	CcSEcCtD
Bimatoprost—Tafluprost—PTGS2—atherosclerosis	0.00263	0.162	CrCbGaD
Bimatoprost—Oedema peripheral—Ezetimibe—atherosclerosis	0.00262	0.00572	CcSEcCtD
Bimatoprost—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00261	0.0057	CcSEcCtD
Bimatoprost—Depression—Pravastatin—atherosclerosis	0.00254	0.00556	CcSEcCtD
Bimatoprost—Cough—Rosuvastatin—atherosclerosis	0.00243	0.00531	CcSEcCtD
Bimatoprost—Angiopathy—Ezetimibe—atherosclerosis	0.00241	0.00527	CcSEcCtD
Bimatoprost—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00239	0.00523	CcSEcCtD
Bimatoprost—Sinusitis—Pravastatin—atherosclerosis	0.00239	0.00523	CcSEcCtD
Bimatoprost—Rhinitis—Niacin—atherosclerosis	0.00233	0.0051	CcSEcCtD
Bimatoprost—Erythema—Ezetimibe—atherosclerosis	0.00231	0.00505	CcSEcCtD
Bimatoprost—Rhinitis—Pravastatin—atherosclerosis	0.0023	0.00502	CcSEcCtD
Bimatoprost—Oedema peripheral—Niacin—atherosclerosis	0.00229	0.00501	CcSEcCtD
Bimatoprost—Pharyngitis—Pravastatin—atherosclerosis	0.00227	0.00497	CcSEcCtD
Bimatoprost—Infection—Rosuvastatin—atherosclerosis	0.00226	0.00493	CcSEcCtD
Bimatoprost—Visual impairment—Niacin—atherosclerosis	0.00224	0.0049	CcSEcCtD
Bimatoprost—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00223	0.00487	CcSEcCtD
Bimatoprost—Vision blurred—Lovastatin—atherosclerosis	0.00222	0.00486	CcSEcCtD
Bimatoprost—Visual impairment—Pravastatin—atherosclerosis	0.00221	0.00482	CcSEcCtD
Bimatoprost—Erythema—Simvastatin—atherosclerosis	0.00221	0.00482	CcSEcCtD
Bimatoprost—Eye disorder—Niacin—atherosclerosis	0.00217	0.00475	CcSEcCtD
Bimatoprost—Vertigo—Lovastatin—atherosclerosis	0.00212	0.00463	CcSEcCtD
Bimatoprost—Angiopathy—Niacin—atherosclerosis	0.00211	0.00461	CcSEcCtD
Bimatoprost—Vision blurred—Simvastatin—atherosclerosis	0.00208	0.00454	CcSEcCtD
Bimatoprost—Insomnia—Rosuvastatin—atherosclerosis	0.00205	0.00449	CcSEcCtD
Bimatoprost—Palpitations—Ezetimibe—atherosclerosis	0.00204	0.00447	CcSEcCtD
Bimatoprost—Erythema—Niacin—atherosclerosis	0.00202	0.00442	CcSEcCtD
Bimatoprost—Cough—Ezetimibe—atherosclerosis	0.00202	0.00441	CcSEcCtD
Bimatoprost—Chest pain—Lovastatin—atherosclerosis	0.00201	0.00439	CcSEcCtD
Bimatoprost—Anxiety—Lovastatin—atherosclerosis	0.002	0.00437	CcSEcCtD
Bimatoprost—Dyspepsia—Rosuvastatin—atherosclerosis	0.002	0.00437	CcSEcCtD
Bimatoprost—Hypertension—Ezetimibe—atherosclerosis	0.002	0.00436	CcSEcCtD
Bimatoprost—Tension—Niacin—atherosclerosis	0.00199	0.00434	CcSEcCtD
Bimatoprost—Vertigo—Simvastatin—atherosclerosis	0.00198	0.00433	CcSEcCtD
Bimatoprost—Chest pain—Ezetimibe—atherosclerosis	0.00197	0.0043	CcSEcCtD
Bimatoprost—Nervousness—Niacin—atherosclerosis	0.00197	0.0043	CcSEcCtD
Bimatoprost—Dry mouth—Lovastatin—atherosclerosis	0.00196	0.00429	CcSEcCtD
Bimatoprost—Tension—Pravastatin—atherosclerosis	0.00196	0.00428	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00196	0.00427	CcSEcCtD
Bimatoprost—Pain—Rosuvastatin—atherosclerosis	0.00194	0.00424	CcSEcCtD
Bimatoprost—Nervousness—Pravastatin—atherosclerosis	0.00194	0.00423	CcSEcCtD
Bimatoprost—Dry mouth—Ezetimibe—atherosclerosis	0.00193	0.00421	CcSEcCtD
Bimatoprost—Infection—Lovastatin—atherosclerosis	0.00191	0.00418	CcSEcCtD
Bimatoprost—Vision blurred—Niacin—atherosclerosis	0.00191	0.00417	CcSEcCtD
Bimatoprost—Vision blurred—Pravastatin—atherosclerosis	0.00188	0.00411	CcSEcCtD
Bimatoprost—Chest pain—Simvastatin—atherosclerosis	0.00188	0.0041	CcSEcCtD
Bimatoprost—Infection—Ezetimibe—atherosclerosis	0.00187	0.0041	CcSEcCtD
Bimatoprost—Anxiety—Simvastatin—atherosclerosis	0.00187	0.00409	CcSEcCtD
Bimatoprost—Nervous system disorder—Ezetimibe—atherosclerosis	0.00185	0.00404	CcSEcCtD
Bimatoprost—Skin disorder—Ezetimibe—atherosclerosis	0.00183	0.00401	CcSEcCtD
Bimatoprost—Vertigo—Niacin—atherosclerosis	0.00182	0.00398	CcSEcCtD
Bimatoprost—Vertigo—Pravastatin—atherosclerosis	0.00179	0.00391	CcSEcCtD
Bimatoprost—Palpitations—Niacin—atherosclerosis	0.00179	0.00391	CcSEcCtD
Bimatoprost—Infection—Simvastatin—atherosclerosis	0.00179	0.00391	CcSEcCtD
Bimatoprost—Cough—Niacin—atherosclerosis	0.00177	0.00386	CcSEcCtD
Bimatoprost—Insomnia—Lovastatin—atherosclerosis	0.00174	0.0038	CcSEcCtD
Bimatoprost—Cough—Pravastatin—atherosclerosis	0.00174	0.0038	CcSEcCtD
Bimatoprost—Hypertension—Pravastatin—atherosclerosis	0.00172	0.00376	CcSEcCtD
Bimatoprost—Dyspnoea—Lovastatin—atherosclerosis	0.00172	0.00375	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00171	0.00374	CcSEcCtD
Bimatoprost—Insomnia—Ezetimibe—atherosclerosis	0.00171	0.00373	CcSEcCtD
Bimatoprost—Chest pain—Pravastatin—atherosclerosis	0.0017	0.00371	CcSEcCtD
Bimatoprost—Dyspepsia—Lovastatin—atherosclerosis	0.00169	0.0037	CcSEcCtD
Bimatoprost—Anxiety—Pravastatin—atherosclerosis	0.00169	0.0037	CcSEcCtD
Bimatoprost—Dry mouth—Niacin—atherosclerosis	0.00169	0.00368	CcSEcCtD
Bimatoprost—Dyspnoea—Ezetimibe—atherosclerosis	0.00168	0.00368	CcSEcCtD
Bimatoprost—Dyspepsia—Ezetimibe—atherosclerosis	0.00166	0.00363	CcSEcCtD
Bimatoprost—Pain—Lovastatin—atherosclerosis	0.00165	0.0036	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00163	0.00356	CcSEcCtD
Bimatoprost—Asthenia—Rosuvastatin—atherosclerosis	0.00163	0.00356	CcSEcCtD
Bimatoprost—Insomnia—Simvastatin—atherosclerosis	0.00163	0.00356	CcSEcCtD
Bimatoprost—Infection—Pravastatin—atherosclerosis	0.00162	0.00353	CcSEcCtD
Bimatoprost—Pain—Ezetimibe—atherosclerosis	0.00161	0.00353	CcSEcCtD
Bimatoprost—Pruritus—Rosuvastatin—atherosclerosis	0.00161	0.00351	CcSEcCtD
Bimatoprost—Skin disorder—Niacin—atherosclerosis	0.00161	0.00351	CcSEcCtD
Bimatoprost—Dyspnoea—Simvastatin—atherosclerosis	0.0016	0.00351	CcSEcCtD
Bimatoprost—Dyspepsia—Simvastatin—atherosclerosis	0.00158	0.00346	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00155	0.0034	CcSEcCtD
Bimatoprost—Pain—Simvastatin—atherosclerosis	0.00154	0.00336	CcSEcCtD
Bimatoprost—Dizziness—Rosuvastatin—atherosclerosis	0.0015	0.00328	CcSEcCtD
Bimatoprost—Insomnia—Niacin—atherosclerosis	0.00149	0.00327	CcSEcCtD
Bimatoprost—Dyspnoea—Niacin—atherosclerosis	0.00147	0.00322	CcSEcCtD
Bimatoprost—Insomnia—Pravastatin—atherosclerosis	0.00147	0.00322	CcSEcCtD
Bimatoprost—Somnolence—Niacin—atherosclerosis	0.00147	0.00321	CcSEcCtD
Bimatoprost—Dyspepsia—Niacin—atherosclerosis	0.00145	0.00318	CcSEcCtD
Bimatoprost—Dyspnoea—Pravastatin—atherosclerosis	0.00145	0.00317	CcSEcCtD
Bimatoprost—Dyspepsia—Pravastatin—atherosclerosis	0.00143	0.00313	CcSEcCtD
Bimatoprost—Rash—Rosuvastatin—atherosclerosis	0.00143	0.00313	CcSEcCtD
Bimatoprost—Dermatitis—Rosuvastatin—atherosclerosis	0.00143	0.00313	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Niacin—atherosclerosis	0.00143	0.00312	CcSEcCtD
Bimatoprost—Headache—Rosuvastatin—atherosclerosis	0.00142	0.00311	CcSEcCtD
Bimatoprost—Pain—Niacin—atherosclerosis	0.00141	0.00309	CcSEcCtD
Bimatoprost—Pain—Pravastatin—atherosclerosis	0.00139	0.00304	CcSEcCtD
Bimatoprost—Asthenia—Lovastatin—atherosclerosis	0.00138	0.00302	CcSEcCtD
Bimatoprost—Pruritus—Lovastatin—atherosclerosis	0.00136	0.00297	CcSEcCtD
Bimatoprost—Asthenia—Ezetimibe—atherosclerosis	0.00135	0.00296	CcSEcCtD
Bimatoprost—Nausea—Rosuvastatin—atherosclerosis	0.00135	0.00295	CcSEcCtD
Bimatoprost—Pruritus—Ezetimibe—atherosclerosis	0.00134	0.00292	CcSEcCtD
Bimatoprost—Asthenia—Simvastatin—atherosclerosis	0.00129	0.00282	CcSEcCtD
Bimatoprost—Pruritus—Simvastatin—atherosclerosis	0.00127	0.00278	CcSEcCtD
Bimatoprost—Dizziness—Lovastatin—atherosclerosis	0.00127	0.00278	CcSEcCtD
Bimatoprost—Dizziness—Ezetimibe—atherosclerosis	0.00125	0.00273	CcSEcCtD
Bimatoprost—Rash—Lovastatin—atherosclerosis	0.00121	0.00265	CcSEcCtD
Bimatoprost—Dermatitis—Lovastatin—atherosclerosis	0.00121	0.00265	CcSEcCtD
Bimatoprost—Headache—Lovastatin—atherosclerosis	0.00121	0.00263	CcSEcCtD
Bimatoprost—Dizziness—Simvastatin—atherosclerosis	0.00119	0.0026	CcSEcCtD
Bimatoprost—Rash—Ezetimibe—atherosclerosis	0.00119	0.0026	CcSEcCtD
Bimatoprost—Dermatitis—Ezetimibe—atherosclerosis	0.00119	0.0026	CcSEcCtD
Bimatoprost—Asthenia—Niacin—atherosclerosis	0.00119	0.00259	CcSEcCtD
Bimatoprost—Headache—Ezetimibe—atherosclerosis	0.00118	0.00258	CcSEcCtD
Bimatoprost—Pruritus—Niacin—atherosclerosis	0.00117	0.00256	CcSEcCtD
Bimatoprost—Asthenia—Pravastatin—atherosclerosis	0.00117	0.00255	CcSEcCtD
Bimatoprost—Pruritus—Pravastatin—atherosclerosis	0.00115	0.00252	CcSEcCtD
Bimatoprost—Nausea—Lovastatin—atherosclerosis	0.00114	0.0025	CcSEcCtD
Bimatoprost—Rash—Simvastatin—atherosclerosis	0.00113	0.00248	CcSEcCtD
Bimatoprost—Dermatitis—Simvastatin—atherosclerosis	0.00113	0.00248	CcSEcCtD
Bimatoprost—Headache—Simvastatin—atherosclerosis	0.00113	0.00246	CcSEcCtD
Bimatoprost—Nausea—Ezetimibe—atherosclerosis	0.00112	0.00245	CcSEcCtD
Bimatoprost—Dizziness—Niacin—atherosclerosis	0.00109	0.00239	CcSEcCtD
Bimatoprost—Dizziness—Pravastatin—atherosclerosis	0.00108	0.00235	CcSEcCtD
Bimatoprost—Nausea—Simvastatin—atherosclerosis	0.00107	0.00234	CcSEcCtD
Bimatoprost—Rash—Niacin—atherosclerosis	0.00104	0.00228	CcSEcCtD
Bimatoprost—Dermatitis—Niacin—atherosclerosis	0.00104	0.00227	CcSEcCtD
Bimatoprost—Headache—Niacin—atherosclerosis	0.00104	0.00226	CcSEcCtD
Bimatoprost—Rash—Pravastatin—atherosclerosis	0.00103	0.00224	CcSEcCtD
Bimatoprost—Dermatitis—Pravastatin—atherosclerosis	0.00103	0.00224	CcSEcCtD
Bimatoprost—Headache—Pravastatin—atherosclerosis	0.00102	0.00223	CcSEcCtD
Bimatoprost—Nausea—Niacin—atherosclerosis	0.000982	0.00215	CcSEcCtD
Bimatoprost—Nausea—Pravastatin—atherosclerosis	0.000967	0.00211	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—KNG1—atherosclerosis	0.000207	0.000393	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOC3—atherosclerosis	0.000206	0.000391	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AGTR1—atherosclerosis	0.000205	0.00039	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LDLR—atherosclerosis	0.000204	0.000388	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—HMGCR—atherosclerosis	0.000204	0.000388	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PRKCG—atherosclerosis	0.000203	0.000387	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VWF—atherosclerosis	0.000203	0.000385	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CCL2—atherosclerosis	0.000201	0.000383	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AGT—atherosclerosis	0.000201	0.000383	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOC3—atherosclerosis	0.000201	0.000383	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LDLR—atherosclerosis	0.0002	0.00038	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PLG—atherosclerosis	0.0002	0.00038	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL3—atherosclerosis	0.0002	0.000379	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AGT—atherosclerosis	0.000197	0.000375	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VWF—atherosclerosis	0.000195	0.000371	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL3—atherosclerosis	0.000195	0.000371	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOC3—atherosclerosis	0.000194	0.000369	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LDLR—atherosclerosis	0.000193	0.000367	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NCF1—atherosclerosis	0.000191	0.000363	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SOCS3—atherosclerosis	0.000189	0.00036	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL3—atherosclerosis	0.000189	0.000358	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NCF1—atherosclerosis	0.000187	0.000356	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—F2—atherosclerosis	0.000186	0.000354	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000184	0.00035	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP3—atherosclerosis	0.000183	0.000348	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AGT—atherosclerosis	0.000183	0.000348	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IGF2—atherosclerosis	0.000182	0.000346	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—F2—atherosclerosis	0.000182	0.000346	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ABCA1—atherosclerosis	0.000182	0.000345	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NCF1—atherosclerosis	0.000181	0.000343	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCR2—atherosclerosis	0.000181	0.000343	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EDNRA—atherosclerosis	0.000181	0.000343	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CYBA—atherosclerosis	0.00018	0.000342	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AGT—atherosclerosis	0.000179	0.00034	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APOB—atherosclerosis	0.000178	0.000339	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000178	0.000338	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APOB—atherosclerosis	0.000177	0.000336	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCR2—atherosclerosis	0.000177	0.000336	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EDNRA—atherosclerosis	0.000177	0.000336	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GHRL—atherosclerosis	0.000176	0.000334	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PARP1—atherosclerosis	0.000176	0.000334	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PLAT—atherosclerosis	0.000176	0.000334	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CYBA—atherosclerosis	0.000176	0.000334	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCL8—atherosclerosis	0.000175	0.000333	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000174	0.000331	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EDN1—atherosclerosis	0.000174	0.000331	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCL5—atherosclerosis	0.000173	0.000328	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GHRL—atherosclerosis	0.000172	0.000327	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PLAT—atherosclerosis	0.000172	0.000327	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PARP1—atherosclerosis	0.000172	0.000327	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCR2—atherosclerosis	0.000171	0.000324	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EDNRA—atherosclerosis	0.000171	0.000324	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—LPL—atherosclerosis	0.00017	0.000324	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CYBA—atherosclerosis	0.00017	0.000323	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—F2—atherosclerosis	0.000169	0.000321	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—LPL—atherosclerosis	0.000169	0.000321	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GHRL—atherosclerosis	0.000166	0.000316	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PARP1—atherosclerosis	0.000166	0.000316	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PLAT—atherosclerosis	0.000166	0.000316	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PRKCG—atherosclerosis	0.000166	0.000315	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—F2—atherosclerosis	0.000165	0.000314	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PRKCG—atherosclerosis	0.000164	0.000312	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CG—atherosclerosis	0.000162	0.000307	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SPP1—atherosclerosis	0.00016	0.000304	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CXCL8—atherosclerosis	0.000159	0.000303	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000158	0.000301	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—HMOX1—atherosclerosis	0.000156	0.000296	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KNG1—atherosclerosis	0.000154	0.000294	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AGTR1—atherosclerosis	0.000154	0.000292	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MTHFR—atherosclerosis	0.000153	0.000291	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KNG1—atherosclerosis	0.000151	0.000287	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCL2—atherosclerosis	0.000151	0.000286	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AGTR1—atherosclerosis	0.00015	0.000286	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PLG—atherosclerosis	0.00015	0.000284	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APOB—atherosclerosis	0.000149	0.000284	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PDGFB—atherosclerosis	0.000149	0.000284	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PDGFB—atherosclerosis	0.000148	0.000281	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCL2—atherosclerosis	0.000147	0.00028	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PLG—atherosclerosis	0.000146	0.000278	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KNG1—atherosclerosis	0.000146	0.000277	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GSTM1—atherosclerosis	0.000145	0.000276	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AGTR1—atherosclerosis	0.000145	0.000276	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AGT—atherosclerosis	0.000144	0.000275	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APOE—atherosclerosis	0.000143	0.000271	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—LPL—atherosclerosis	0.000143	0.000271	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SOCS3—atherosclerosis	0.000142	0.000269	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—LEP—atherosclerosis	0.000142	0.000269	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APOE—atherosclerosis	0.000142	0.000269	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CAV1—atherosclerosis	0.000141	0.000269	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PLG—atherosclerosis	0.000141	0.000269	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APOA1—atherosclerosis	0.000141	0.000268	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CAV1—atherosclerosis	0.00014	0.000267	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APOA1—atherosclerosis	0.00014	0.000266	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GPX1—atherosclerosis	0.000139	0.000264	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SOCS3—atherosclerosis	0.000139	0.000264	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP3—atherosclerosis	0.000137	0.00026	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF2—atherosclerosis	0.000136	0.000259	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CD36—atherosclerosis	0.000136	0.000258	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ESR1—atherosclerosis	0.000135	0.000257	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP3—atherosclerosis	0.000134	0.000255	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SOCS3—atherosclerosis	0.000134	0.000254	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—F2—atherosclerosis	0.000133	0.000254	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF2—atherosclerosis	0.000133	0.000253	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOS2—atherosclerosis	0.000133	0.000253	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOB—atherosclerosis	0.000132	0.000251	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCL8—atherosclerosis	0.000131	0.000249	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EDN1—atherosclerosis	0.00013	0.000247	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOB—atherosclerosis	0.000129	0.000246	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP3—atherosclerosis	0.000129	0.000246	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL5—atherosclerosis	0.000129	0.000245	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF2—atherosclerosis	0.000129	0.000245	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—MTHFR—atherosclerosis	0.000128	0.000244	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000128	0.000244	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CG—atherosclerosis	0.000128	0.000243	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EDN1—atherosclerosis	0.000127	0.000242	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL5—atherosclerosis	0.000126	0.00024	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LPL—atherosclerosis	0.000126	0.00024	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PPARA—atherosclerosis	0.000126	0.000239	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOB—atherosclerosis	0.000125	0.000237	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LPL—atherosclerosis	0.000124	0.000235	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EDN1—atherosclerosis	0.000123	0.000234	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PRKCG—atherosclerosis	0.000123	0.000233	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—MAPK3—atherosclerosis	0.000122	0.000233	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AGT—atherosclerosis	0.000122	0.000232	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL5—atherosclerosis	0.000122	0.000232	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—INS—atherosclerosis	0.000122	0.000232	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—INS—atherosclerosis	0.000121	0.00023	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PRKCG—atherosclerosis	0.00012	0.000228	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SPP1—atherosclerosis	0.00012	0.000227	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APOE—atherosclerosis	0.00012	0.000227	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LPL—atherosclerosis	0.000119	0.000227	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL8—atherosclerosis	0.000119	0.000226	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCL2—atherosclerosis	0.000119	0.000226	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CAV1—atherosclerosis	0.000118	0.000225	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APOA1—atherosclerosis	0.000118	0.000225	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SPP1—atherosclerosis	0.000117	0.000222	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IGF1—atherosclerosis	0.000117	0.000222	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL8—atherosclerosis	0.000117	0.000222	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PRKCG—atherosclerosis	0.000116	0.00022	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SPP1—atherosclerosis	0.000113	0.000215	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SERPINE1—atherosclerosis	0.000112	0.000213	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SERPINE1—atherosclerosis	0.000111	0.000211	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PDGFB—atherosclerosis	0.000111	0.00021	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PDGFB—atherosclerosis	0.000108	0.000206	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AGT—atherosclerosis	0.000108	0.000205	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CG—atherosclerosis	0.000108	0.000205	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOS3—atherosclerosis	0.000107	0.000203	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NOS3—atherosclerosis	0.000106	0.000202	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LEP—atherosclerosis	0.000106	0.000201	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOE—atherosclerosis	0.000106	0.000201	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AGT—atherosclerosis	0.000106	0.000201	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CAV1—atherosclerosis	0.000105	0.000199	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOA1—atherosclerosis	0.000105	0.000199	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PDGFB—atherosclerosis	0.000105	0.000199	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PPARG—atherosclerosis	0.000104	0.000198	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOE—atherosclerosis	0.000104	0.000197	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LEP—atherosclerosis	0.000104	0.000197	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CAV1—atherosclerosis	0.000103	0.000195	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOA1—atherosclerosis	0.000102	0.000195	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—INS—atherosclerosis	0.000102	0.000194	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AGT—atherosclerosis	0.000102	0.000194	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ESR1—atherosclerosis	0.000101	0.000192	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LEP—atherosclerosis	0.0001	0.00019	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOE—atherosclerosis	0.0001	0.00019	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—F2—atherosclerosis	9.98e-05	0.00019	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CAV1—atherosclerosis	9.9e-05	0.000188	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ESR1—atherosclerosis	9.89e-05	0.000188	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOA1—atherosclerosis	9.88e-05	0.000188	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—atherosclerosis	9.78e-05	0.000186	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—F2—atherosclerosis	9.77e-05	0.000186	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CG—atherosclerosis	9.55e-05	0.000182	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ESR1—atherosclerosis	9.54e-05	0.000181	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—F2—atherosclerosis	9.43e-05	0.000179	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL8—atherosclerosis	9.41e-05	0.000179	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ALB—atherosclerosis	9.36e-05	0.000178	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CG—atherosclerosis	9.35e-05	0.000178	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—MAPK3—atherosclerosis	9.15e-05	0.000174	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AKT1—atherosclerosis	9.09e-05	0.000173	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—INS—atherosclerosis	9.04e-05	0.000172	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CG—atherosclerosis	9.02e-05	0.000171	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—NOS3—atherosclerosis	8.96e-05	0.00017	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—MAPK3—atherosclerosis	8.96e-05	0.00017	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—atherosclerosis	8.95e-05	0.00017	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL2—atherosclerosis	8.9e-05	0.000169	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—INS—atherosclerosis	8.85e-05	0.000168	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF1—atherosclerosis	8.75e-05	0.000166	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL2—atherosclerosis	8.71e-05	0.000166	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF1—atherosclerosis	8.56e-05	0.000163	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—INS—atherosclerosis	8.54e-05	0.000162	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP9—atherosclerosis	8.51e-05	0.000162	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NFKB1—atherosclerosis	8.42e-05	0.00016	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL2—atherosclerosis	8.4e-05	0.00016	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SERPINE1—atherosclerosis	8.31e-05	0.000158	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAPK8—atherosclerosis	8.28e-05	0.000157	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF1—atherosclerosis	8.26e-05	0.000157	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AKT1—atherosclerosis	8.25e-05	0.000157	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—atherosclerosis	8.19e-05	0.000156	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SERPINE1—atherosclerosis	8.13e-05	0.000155	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOS3—atherosclerosis	7.93e-05	0.000151	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SERPINE1—atherosclerosis	7.84e-05	0.000149	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOS3—atherosclerosis	7.76e-05	0.000148	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—atherosclerosis	7.64e-05	0.000145	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—STAT3—atherosclerosis	7.63e-05	0.000145	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STAT3—atherosclerosis	7.57e-05	0.000144	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOS3—atherosclerosis	7.49e-05	0.000142	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MAPK3—atherosclerosis	7.29e-05	0.000139	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAPK3—atherosclerosis	7.23e-05	0.000137	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TGFB1—atherosclerosis	7.07e-05	0.000134	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL8—atherosclerosis	7.03e-05	0.000134	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TGFB1—atherosclerosis	7.01e-05	0.000133	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL8—atherosclerosis	6.89e-05	0.000131	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AKT1—atherosclerosis	6.8e-05	0.000129	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—atherosclerosis	6.69e-05	0.000127	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AKT1—atherosclerosis	6.65e-05	0.000126	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL8—atherosclerosis	6.64e-05	0.000126	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—atherosclerosis	6.55e-05	0.000124	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP9—atherosclerosis	6.36e-05	0.000121	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NFKB1—atherosclerosis	6.29e-05	0.00012	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP9—atherosclerosis	6.23e-05	0.000118	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAPK8—atherosclerosis	6.19e-05	0.000118	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AKT1—atherosclerosis	6.17e-05	0.000117	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NFKB1—atherosclerosis	6.16e-05	0.000117	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAPK8—atherosclerosis	6.06e-05	0.000115	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKT1—atherosclerosis	6.04e-05	0.000115	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP9—atherosclerosis	6.01e-05	0.000114	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NFKB1—atherosclerosis	5.94e-05	0.000113	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAPK8—atherosclerosis	5.84e-05	0.000111	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—atherosclerosis	5.71e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STAT3—atherosclerosis	5.66e-05	0.000108	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—atherosclerosis	5.59e-05	0.000106	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STAT3—atherosclerosis	5.54e-05	0.000105	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAPK3—atherosclerosis	5.4e-05	0.000103	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—atherosclerosis	5.4e-05	0.000103	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STAT3—atherosclerosis	5.34e-05	0.000102	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—atherosclerosis	5.33e-05	0.000101	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAPK3—atherosclerosis	5.29e-05	0.000101	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—atherosclerosis	5.28e-05	0.0001	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TGFB1—atherosclerosis	5.24e-05	9.97e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TGFB1—atherosclerosis	5.13e-05	9.75e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAPK3—atherosclerosis	5.1e-05	9.7e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TGFB1—atherosclerosis	4.95e-05	9.41e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT1—atherosclerosis	4.92e-05	9.34e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT1—atherosclerosis	4.87e-05	9.26e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AKT1—atherosclerosis	4.12e-05	7.82e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—atherosclerosis	3.95e-05	7.51e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—atherosclerosis	3.87e-05	7.35e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—atherosclerosis	3.73e-05	7.09e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT1—atherosclerosis	3.65e-05	6.93e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT1—atherosclerosis	3.57e-05	6.78e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT1—atherosclerosis	3.44e-05	6.54e-05	CbGpPWpGaD
